Using electronic tools to identify risks of opioid misuse and overdose
Official title: Feasibility of Electronic Screening to Identify Risk of Opioid Misuse and Overdose
Funded at Oprems LLC · NIH-10822394 · Data updated 2026-11-12
This study is testing a new digital way to help doctors and pharmacists better identify patients who might be at risk for misusing opioids, so they can provide the right support and education, especially about using naloxone to prevent overdoses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oprems LLC NIH-funded |
| Lab location | 1 site (Northbrook, United States) |
| Project start | September 15, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $295,876 |
| NIH project number | 1R41DA060000-01 |
| Project ID | NIH-10822394 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include patients who are currently prescribed opioid medications and may be at risk for misuse.
✕Less likely to help
Patients who are not prescribed opioids or who do not have any risk factors for opioid misuse may not benefit from this research.
What this research studies
This research aims to enhance the screening process for patients prescribed opioids by transitioning from a paper-based system to a digital platform. By utilizing tablet PCs, the project seeks to improve the consistency and effectiveness of identifying individuals at risk for opioid misuse and overdose. The program, known as ONE, has already shown promising results in community pharmacies, where it has significantly increased the dispensing of naloxone, a medication that can reverse opioid overdoses. The goal is to provide targeted interventions and education to patients based on their screening results.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention strategies for opioid misuse and overdose, ultimately saving lives.
How similar studies have gone: Previous implementations of the ONE program have shown success in increasing naloxone dispensing rates, indicating that similar approaches may be effective.
Where this research is happening
-
Oprems LLC
Northbrook, United States Active
Researchers
- Principal investigator: Ferrarese, Nick — Oprems LLC
- Study coordinator: Ferrarese, Nick
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.